Clinical trial
A Randomized, Open Label, Multicenter, Phase II, 2-Arm Study comparing the conventional 3 weekly schedule of Jevtana (Cabazitaxel) with a weekly regimen in patients with Metastastic Castration Resistant Prostate CancerConWeCab
To determine if a weekly regime improves tolerability of cabazitaxel compared to the standard 3 week regimen
| Category | Value |
|---|---|
| Study start date | 2011-12-19 |